BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas

18Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Recent studies have shown that BRAFV600E mutation is associated with poor prognostic factors in papillary thyroid carcinoma (PTC). However, there are no studies about the association of the BRAFV600E mutation with poor prognostic factors according to tumor size in PTC. Methods: We investigated the prevalence of the BRAFV600E mutation and its association with prognostic factors according to tumor size of PTC. BRAF V600E mutation status was assessed in thyroid fine-needle aspiration (FNA) specimens from 605 patients before thyroidectomy for PTC, and its association with postoperative clinicopathologic factors was evaluated. Results: The overall prevalence of the BRAFV600E mutation was 67%, and larger tumors more often had the BRAFV600E mutation (p for trend

Cite

CITATION STYLE

APA

Lee, J. I., Jang, H. W., Kim, S. W., Kim, J. W., Oh, Y. L., & Chung, J. H. (2013). BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas. Head and Neck, 35(4), 548–553. https://doi.org/10.1002/hed.22997

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free